UBS Group
GNLX icon

UBS Group’s Genelux GNLX Stock Holding History

UBS Group’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
122,579
+75,219
+159% +$205K ﹤0.01% 6413
2025
Q4 		$206K Buy
47,360
+19,581
+70% +$106K ﹤0.01% 6560
2025
Q3 		$117K Sell
27,779
-43,445
-61% -$154K ﹤0.01% 7011
2025
Q2 		$204K Buy
71,224
+3,088
+5% +$8.16K ﹤0.01% 6707
2025
Q1 		$184K Buy
68,136
+43,045
+172% +$161K ﹤0.01% 6609
2024
Q4 		$59.2K Sell
25,091
-14,998
-37% -$39.9K ﹤0.01% 7190
2024
Q3 		$95K Buy
40,089
+8,457
+27% +$18.6K ﹤0.01% 6411
2024
Q2 		$61.7K Sell
31,632
-12,484
-28% -$42.4K ﹤0.01% 6527
2024
Q1 		$284K Buy
44,116
+23,786
+117% +$216K ﹤0.01% 5607
2023
Q4 		$285K Buy
20,330
+10,305
+103% +$163K ﹤0.01% 5537
2023
Q3 		$246K Buy
10,025
+7,008
+232% +$178K ﹤0.01% 5217
2023
Q2 		$98.7K Buy
3,017
+2,833
+1,540% +$79.7K ﹤0.01% 6026
2023
Q1 		$5.1K Buy
+184
New +$2.98K ﹤0.01% 8086

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group's GNLX Position: Q1 2026 in Review

UBS Group increased its Genelux (GNLX) stake by 159% in Q1 2026, buying an estimated $205K and bringing the position to 122,579 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #6413.

UBS Group first reported a position in GNLX in Q1 2023 and has held it in 13 quarters since. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • UBS Group held 122,579 shares of Genelux worth $297K as of Q1 2026.
  • UBS Group bought 75,219 Genelux shares in Q1 2026, an estimated $205K.
  • Genelux made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6413 holding.
  • UBS Group first reported a position in Genelux in Q1 2023 and has held it in 13 quarters since.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.